Delay for Edwards-JenaValve US merger trial would be 'unprecedented,' companies say
MLex Summary: Edwards Lifesciences and JenaValve Technology urged a US district court to deny the US Federal Trade Commission's request for a stay of the companies' merger trial due to the...To view the full article, register now.
Already a subscriber? Click here to view full article